Managing intracranial aneurysms relies on assessing rupture risk, a process that traditionally depends on manual analysis of MRI and CT scans, which can be time-consuming and subjective. This can lead to delayed or inaccurate risk predictions, impacting treatment planning and patient outcomes.

Sim4Flow's IRIS is a cloud-based platform that employs AI to provide precise, patient-specific insights for intracranial aneurysm management. By analyzing MRI and CT scans, IRIS offers clinicians an advanced tool for assessing the rupture risks of unruptured intracranial aneurysms. The platform leverages machine learning and explainable AI (xAI) to deliver transparent and understandable results, enabling well-informed, proactive decisions that enhance patient care. The AI algorithms analyze the scan to identify potential aneurysms and assess their rupture risk, generating a comprehensive report with insights into aneurysm size, location, and rupture likelihood.

AI-driven analysis of MRI and CT scans for aneurysm identification and risk assessment

Machine learning models for accurate and personalized risk predictions

Explainable AI (xAI) for transparent and understandable results

Cloud-based platform for easy access and scalability

Detailed reports providing insights into aneurysm size, location, and rupture likelihood

The primary users are healthcare providers, including clinicians and researchers, involved in the management of intracranial aneurysms.